Novartis divests Miochol-E to prep for Alcon buy
Bausch & Lomb Inc. has purchased from affiliates of Novartis AG a portion of the Miochol-E (acetylcholine) assets in the US, Canada, Australia, and Korea, as well as parts outside the European Economic Area. It will buy the remainder upon regulatory clearance.
- Marketing (Licensing)
- Product Purchase
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com